Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?

Table 1 Baseline characteristics and laboratory findings of 332 patients hospitalized with coronavirus disease 2019 in three Italian hospitals

Factor	Total 332 patients
Age in yr, median (range)	71.9 (19-100)
Male, n (%)	178 (59.7)
BMI in kg/m2, mean (range)	26.6 (17-42.7)
Arterial hypertension, n (%)	97 (29.2)
Glucose levels in mg/dL, mean (range)	109.4 (48-505)
Baseline ALT levels in U/L, median (range)	39.1 (4-429)
ALT of > 40 U/L, n (%)	74 (25.8)
Baseline AST levels in U/L, mean (range)	44.7 (7-817)
ALT of > 60 U/L, n (%)	82 (28.7)
Liver cirrhosis, n (%)	10.0 (3.0)
Baseline WBC count as × 109/L, mean ± SD	8.14 ± 6.28
Neutrophil count as × 109/L, mean ± SD	7.37 ± 10.84
Lymphocyte count as × 109/L, mean ± SD	1.54 ± 3.03
Lymphocyte count < 1000 as × 109/L, n (%)	160 (50.3)
Platelet count as × 109/L, mean ± SD	227.1 ± 107.5
Total bilirubin in mg/dL, mean (range)	0.79 (0.5-37.0)

BMI: Body mass index; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; SD: Standard deviation; WBC: White blood cell.